| Назив: | A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor |
Аутори: | Fallacara, Ana Lucia; Zamperini, Claudio; Podolski-Renić, Ana   ; Dinić, Jelena ; Stanković, Tijana; Nešović, Marija ; Mancini, Arianna; Rango, Enrico; Iovenitti, Giulia; Molinari, Alessio;
Bugli, Francesca; Sanguinetti, Maurizio; Torelli, Riccardo; Martini, Maurizio; Maccari, Laura; Valoti, Massimo; Dreassi, Elena; Botta, Maurizio; Pešić, Milica ; Schenone, Silvia;
|
Година: | 2019 |
Публикација: | Cancers |
ISSN: | 2072-6694 Cancers Претражи идентификатор |
Тип резултата: | Научни чланак |
Колација: | vol. 11 br. 6 str. 848-848 |
DOI: | 10.3390/cancers11060848 |
WoS-ID: | 000475351200112 |
Scopus-ID: | 2-s2.0-85071177551 |
PMID: | 31248184 |
URI: | https://radar.ibiss.bg.ac.rs/handle/123456789/3379
https://enauka.gov.rs/handle/123456789/432620 |
URL: | https://www.mdpi.com/2072-6694/11/6/848 |
Пројекат: | Identifikacija molekularnih markera za predikciju progresije tumora, odgovora na terapiju i ishoda bolesti (RS-41031)
COST Actions CM1106—Chemical Approaches to Targeting Drug Resistance in Cancer Stem Cells
COST Action CM1407—Challenging organic syntheses inspired by nature—from natural products chemistry to drug discovery
AIRC (Associazione Italiana per la Ricerca sul Cancro) Grant IG-2015, code 17677 |
М-категорија: | 21M21 - Рад у врхунском међ. часопису |
